Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection
Clinical trial NCT00962936 · TERMINATED
Trial details
- NCT number
- NCT00962936
- Sponsor
- CureTech Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-10-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.